Phase I/II clinical trial of MVA85A in individuals with latent tuberculosis: The first subunit TB vaccine in clinical trial by Sander, C, Pathan, A, Gleeson, F, Davies, R, Pasvol, G, VanWijgerden, J, Hill, A, Mcshane, H

Safety and immunogenicity of a new tuberculosis vaccine, MVA85A, in Mycobacterium tuberculosis-infected individuals. by Sander, C, Pathan, A, Beveridge, N, Poulton, I, Minassian, A, Alder, N, Van Wijgerden, J, Hill, A, Gleeson, F, Davies, R, Pasvol, G, Mcshane, H

Attitudinal and demographic predictors of measles-mumps-rubella vaccine (MMR) uptake during the UK catch-up campaign 2008-09: cross-sectional survey by Brown, K, Fraser, G, Ramsay, M, Shanley, R, Cowley, N, Van Wijgerden, J, Toff, P, Falconer, M, Hudson, M, Green, J, Kroll, J, Vincent, C, Sevdalis, N

Attitudinal and demographic predictors of measles, mumps and rubella (MMR) vaccine acceptance: development and validation of an evidence-based measurement instrument. by Brown, K, Shanley, R, Cowley, N, van Wijgerden, J, Toff, P, Falconer, M, Ramsay, M, Hudson, M, Green, J, Vincent, C, Kroll, J, Fraser, G, Sevdalis, N